Jerusalem-based Teva Pharmaceuticals’ sensor-packed, app-connected digital inhaler has recently received marketing approval from the US FDA, according to a release from the company. The device will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback